Search Results - "Elgazwi, Sara M."

Novel EGFR‐MAPK kinase and ABC transporter inhibitors for HepG2 resistant to Erlotinib by Ostlund, Trevor, SutraDhar, Kakan, Elgazwi, Sara M., Mahnashi, Mater, Kyeremateng, Jennifer, Iram, Surtaj, Halaweish, Fathi

“…Hepatocellular carcinoma (HCC) is the third‐leading cause of cancer death in the world, with outlook for most patients having a 5‐year survivability of less…”
Get full text

Cucurbitacins inspired organic synthesis: Potential dual inhibitors targeting EGFR – MAPK pathway by Mahnashi, Mater, Elgazwi, Sara M., Ahmed, Mahmoud Salama, Halaweish, Fathi T.

“…Natural products have been known as a fundamental source for drug discovery leading to the evolution of Biological Oriented Organic Synthesis (BIOS) approach…”
Get full text

Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells by Ismail, Rania S.M., Abou-Seri, Sahar M., Eldehna, Wagdy M., Ismail, Nasser S.M., Elgazwi, Sara M., Ghabbour, Hazem A., Ahmed, Mahmoud Salama, Halaweish, Fathi T., Abou El Ella, Dalal A.

“…Epidermal growth factor receptor (EGFR) signaling pathway has been previously investigated for its significant role in the progression of different types of…”
Get full text

Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma by Elshaier, Yaseen A.M.M., Shaaban, Mohamed A., Abd El Hamid, Mohammed K., Abdelrahman, Mostafa H., Abou-Salim, Mahrous A., Elgazwi, Sara M., Halaweish, Fathi

“…[Display omitted] A new series of pyrazolo[3,4-d]pyrimidines tethered with nitric oxide (NO) producing functionality was designed and synthesized…”
Get full text